|
ABVC
|
ABVC Biopharma, Inc.
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
US
|
NASDAQ
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
US
|
NASDAQ
|
|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
US
|
NASDAQ
|
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SYRS
|
Syros Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VINC
|
Vincera Pharma, Inc.
|
US
|
NASDAQ
|
|
NPNKF
|
Nippon Shinyaku Co. Ltd
|
US
|
OTC
|
|
HEMO
|
Hemogenyx Pharmaceuticals Plc
|
UK
|
LSE
|
|
CYAD
|
Celyad SA
|
BE
|
BR
|
|
1FG
|
FibroGen Inc
|
DE
|
F
|
|
1875
|
Tot Biopharm International Co Ltd
|
HK
|
HK
|
|
6160
|
Beigene Ltd
|
HK
|
HK
|
|
9926
|
Akeso Inc
|
HK
|
HK
|
|
BGBIO
|
Bergenbio ASA
|
NO
|
OL
|